Speciality: Pediatrics
Description:
A warm welcome to all the medical professionals in this interesting session on recent advances in pediatric vasculitis.
Pediatric vasculitis has seen significant advancements in recent years, particularly in understanding the role of genetics and the immune system. Researchers have identified genetic factors linked to the susceptibility of certain vasculitis types, such as Kawasaki disease, improving early diagnosis and personalized treatment.
In treatment, biologic therapies, especially those targeting specific immune pathways like TNF inhibitors and IL-1 blockers, have shown promise in managing vasculitis more effectively. These treatments provide new options for patients unresponsive to conventional therapies.
Another breakthrough is the development of non-invasive imaging techniques, such as advanced MRI and PET scans, which allow for better monitoring of disease activity and response to therapy, reducing the need for invasive procedures like biopsies.
Collaborative efforts through global registries and research networks are also helping to gather more data on pediatric vasculitis. This has led to more standardized diagnostic criteria and treatment protocols, enhancing outcomes for young patients.
Lastly, improved awareness and education among healthcare providers have resulted in earlier recognition and intervention, preventing long-term complications. This progress represents a hopeful outlook for managing pediatric vasculitis in the coming years.
Therefore, get an overall knowledge of recent advances in pediatric vasculitis. Lis
See More Webinars @ Hidoc Webinars
1.
Parkinson patient's gait is restored by a spinal cord stimulator.
2.
A single-cell analysis reveals a distinctive immunosuppressive tumor microenvironment in kidney cancer brain metastases.
3.
Next Day Mood Is Affected by Ability to Recover From Work.
4.
Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness
5.
Children with cancer experience much less pain at home when using a pain monitoring app.
1.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
2.
Cancer Trials 2025: Vaccines, Metabolic Targets, and the Microbiome in Oncology
3.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
4.
The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects
5.
The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
4.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation